
FDA’s Approach to Nitrosamine Control: Innovative Solutions for Drug Safety and Compliance
Understanding Nitrosamine Impurities in Pharmaceuticals: Nitrosamines, particularly N-nitrosamines, are probable or possible human carcinogens. They can form during the synthesis